Quick Overview: On December 11, 2025, Eli Lilly announced positive We covered the weight loss side of Retatrutide last episode. Today the conversation goes deeper. The In this episode, we cover breaking news regarding Eli Lilly's latest phase three
Triumph 4 Topline Data Highlights - Detailed Overview & Context
On December 11, 2025, Eli Lilly announced positive We covered the weight loss side of Retatrutide last episode. Today the conversation goes deeper. The In this episode, we cover breaking news regarding Eli Lilly's latest phase three Coaching application Like if you enjoyed and subscribe for more! GLP-1 + Peptide News This Week — your weekly clinical breakdown of what actually matters in the world of GLP-1s and peptides. Semaglutide changed the weight loss landscape Tirzepatide improved results and Retatrutide takes metabolic therapy further ...
Big health news! Eli Lilly's next-gen obesity drug, retatrutide, just cleared a major Phase 3 milestone. Nicknamed the "Triple G" ... Retatrutide long-term side effects are not yet fully established, as the drug remains investigational and unlicensed in the UK.
